Observational data suggest apixaban leads to fewer thromboembolic events but higher bleeding risk, highlighting the need for ...
Patients who received neoadjuvant systemic therapy followed by surgical resection for mucosal HNSCC in the US National Cancer Database (2004-2022) were evaluated using 1:5 propensity score matching to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results